home / stock / bvs / bvs news


BVS News and Press, Bioventus Inc. From 03/02/23

Stock Information

Company Name: Bioventus Inc.
Stock Symbol: BVS
Market: NASDAQ
Website: bioventus.com

Menu

BVS BVS Quote BVS Short BVS News BVS Articles BVS Message Board
Get BVS Alerts

News, Short Squeeze, Breakout and More Instantly...

BVS - Tesla, Shell, Snowflake among premarket losers' pack

Silvergate Capital SI -43% after crypto bank delays SEC filing; J.P. Morgan turns bearish . Funko FNKO -26% on Q4 earnings release . ZimVie ZIMV -23% on Q4 earnings release . Cano Health CANO -20% on Q4 earnings release . Aehr Test ( AEHR ) -2...

BVS - Cardio Diagnostics, Bioventus top healthcare gainers; ContraFect, AdaptHealth among losers

Gainers: Cardio Diagnostics ( CDIO ) +159% . Bioventus ( BVS ) +68% . CNS Pharmaceuticals ( CNSP ) +24% . Bullfrog AI ( BFRG ) +20% . SI-BONE ( SIBN ) +19% . Losers: ContraFect ( CFRX ) -24% . AdaptHealth ( AHCO ) ...

BVS - Deadline in Lawsuit for Investors who Lost over $100,000 in shares of Bioventus Inc. between February 2021 and November 2022 announced by Shareholders Foundation

Deadline in Lawsuit for Investors who Lost over $100,000 in shares of Bioventus Inc. between February 2021 and November 2022 announced by Shareholders Foundation PR Newswire SAN DIEGO , Feb. 28, 2023 /PRNewswire/ -- The Shareholders Foundation, Inc. announced tha...

BVS - Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality - Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition

DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has entered into a Settlement Agreement (the “Settlement Agreement”...

BVS - Bioventus Deadline Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Bioventus To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 24, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, ...

BVS - Bioventus Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

Boston, Massachusetts--(Newsfile Corp. - January 24, 2023) - Block & Leviton announces that a class action lawsuit has been filed against Bioventus, Inc. (NASDAQ: BVS) for securities law violations. Investors who purchased shares and have lost money are encouraged to contact the firm to l...

BVS - Bioventus Shareholder Action Reminder

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Bioventus To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 18, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...

BVS - Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present at the 41 st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 5...

BVS - Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance

DURHAM, N.C., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today amended its previously announced financial results for the three and nine months ended October 1, 2022. Due to the...

BVS - Bioventus Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - November 18, 2022) - Block & Leviton is investigating Bioventus, Inc. (NASDAQ: BVS) for potential securities law violations. Investors who have lost money in their Bioventus, Inc. investment should contact the firm  to learn more about how the...

Previous 10 Next 10